DAM
AVXL icon

Deltec Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Deltec Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,000
Closed -$59K – 173
2016
Q4 		$59K Hold
15,000
– – 0.01% 157
2016
Q3 		$54K Buy
+15,000
New +$63.2K 0.01% 156

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deltec Asset Management's AVXL Position: Q1 2017 in Review

Deltec Asset Management sold out of Anavex Life Sciences (AVXL) in Q1 2017, closing a stake of 15,000 shares — an estimated $59K sold.

Deltec Asset Management first reported a position in AVXL in Q3 2016 and held it in 2 quarters. The position peaked at $59K in Q4 2016. 58 funds tracked by Wall St. Rank hold AVXL as of Q1 2017.

  • Deltec Asset Management reported no remaining Anavex Life Sciences position as of Q1 2017 after selling out during the quarter.
  • Deltec Asset Management sold 15,000 Anavex Life Sciences shares in Q1 2017, an estimated $59K.
  • Deltec Asset Management first reported a position in Anavex Life Sciences in Q3 2016 and held it in 2 quarters.
  • Deltec Asset Management's Anavex Life Sciences position peaked at $59K in Q4 2016.
  • 58 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2017.

Based on Deltec Asset Management's 13F filing for Q1 2017, filed 26 Apr 2017.